|
| 33886373 | Gracilis Flap Reconstruction After Proctocolectomy for Malignancy and Inflammatory Bowel Disease. | Am Surg | 2023 |
| 37749459 | Segmental Duodenal Resections: Toward Defining Indications, Complexity, and Coding. | J Gastrointest Surg | 2023 |
| 37652810 | Nationwide analysis of unplanned conversion during minimally invasive distal pancreatectomy for pancreatic adenocarcinoma. | HPB (Oxford) | 2023 |
| 37540976 | Impact of Medicaid Expansion on Abdominal Surgery Morbidity, Mortality, and Hospital Readmission. | J Surg Res | 2023 |
| 37078771 | Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial. | JAMA | 2023 |
| 32541227 | The Fistula Risk Score Catalog: Toward Precision Medicine for Pancreatic Fistula After Pancreatoduodenectomy. | Ann Surg | 2022 |
| 35768717 | Tumor Location in the Pancreatic Tail Is Associated with Decreased Likelihood of Receiving Chemotherapy for Pancreatic Adenocarcinoma. | J Gastrointest Surg | 2022 |
| 36333531 | Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore. | Commun Biol | 2022 |
| 35012359 | Early Postoperative Extubation is Associated with Shorter Hospitalization and Improved Short-Term Survival in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. | Am Surg | 2022 |
| 34433515 | A risk-adjusted analysis of drain use in pancreaticoduodenectomy: Some is good, but more may not be better. | Surgery | 2022 |
| 33201132 | The Influence of Intraoperative Blood Loss on Fistula Development Following Pancreatoduodenectomy. | Ann Surg | 2022 |
| 33386129 | Surgeon experience contributes to improved outcomes in pancreatoduodenectomies at high risk for fistula development. | Surgery | 2021 |
| 33845462 | Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2021 |
| 32209323 | The utilization and impact of adjuvant therapy following neoadjuvant therapy and resection of pancreatic adenocarcinoma: does more really matter? | HPB (Oxford) | 2020 |
| 31902137 | The impact of race and socioeconomic status on the presentation, management and outcomes for gastric cancer patients: Analysis from a metropolitan area in the southeast United States. | J Surg Oncol | 2020 |
| 31819177 | Protein kinase D1 regulates metabolic switch in pancreatic cancer via modulation of mTORC1. | Br J Cancer | 2020 |
| 32624291 | Development and external validation of a prediction model for survival in patients with resected ampullary adenocarcinoma. | Eur J Surg Oncol | 2020 |
| 28857813 | Risk Factors and Mitigation Strategies for Pancreatic Fistula After Distal Pancreatectomy: Analysis of 2026 Resections From the International, Multi-institutional Distal Pancreatectomy Study Group. | Ann Surg | 2019 |
| 31908221 | Rising BMI Is Associated with Increased Rate of Clinically Relevant Pancreatic Fistula after Distal Pancreatectomy for Pancreatic Adenocarcinoma. | Am Surg | 2019 |
| 30117090 | Outcomes Following Resection of Hepatocellular Carcinoma in the Absence of Cirrhosis. | J Gastrointest Cancer | 2019 |
| 30115565 | Transmembrane mucin MUC13 distinguishes intraductal papillary mucinous neoplasms from non-mucinous cysts and is associated with high-risk lesions. | HPB (Oxford) | 2019 |
| 30865919 | Pancreatic Adenocarcinoma, Version 1.2019. | J Natl Compr Canc Netw | 2019 |
| 31141112 | Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary Carcinoma. | JAMA Surg | 2019 |
| 30999154 | Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer. | Biomaterials | 2019 |
| 30456682 | Long-Term Implications of Unplanned Conversion During Laparoscopic Liver Resection for Hepatocellular Carcinoma. | Ann Surg Oncol | 2019 |
| 30509457 | Hypervascular lesions of the pancreas: Think before you act. | Am J Surg | 2019 |
| 29427136 | Molecular Alterations Associated with DNA Repair in Pancreatic Adenocarcinoma Are Associated with Sites of Recurrence. | J Gastrointest Cancer | 2019 |
| 28840459 | Pancreatogastrostomy Vs. Pancreatojejunostomy: a Risk-Stratified Analysis of 5316 Pancreatoduodenectomies. | J Gastrointest Surg | 2018 |
| 29804849 | The impact of unplanned conversion to an open procedure during minimally invasive pancreatectomy. | J Surg Res | 2018 |
| 29878371 | Desmoplastic small round cell tumor: A nationwide study of a rare sarcoma. | J Surg Oncol | 2018 |
| 29518820 | Ampullary adenocarcinoma: Defining predictors of survival and the impact of adjuvant therapy following surgical resection for stage I disease. | J Surg Oncol | 2018 |
| 29352660 | Clinical significance of MUC13 in pancreatic ductal adenocarcinoma. | HPB (Oxford) | 2018 |
| 28594741 | Characterization and Optimal Management of High-risk Pancreatic Anastomoses During Pancreatoduodenectomy. | Ann Surg | 2018 |
| 27321183 | MUC13 interaction with receptor tyrosine kinase HER2 drives pancreatic ductal adenocarcinoma progression. | Oncogene | 2017 |
| 28285709 | Management and outcomes following pancreaticoduodenectomy for ampullary adenocarcinoma. | Am J Surg | 2017 |
| 28205125 | Does Hyperbilirubinemia Contribute to Adverse Patient Outcomes Following Pancreatoduodenectomy? | J Gastrointest Surg | 2017 |
| 28784865 | Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2017 |
| 28692468 | A Prospective Randomized Multicenter Trial of Distal Pancreatectomy With and Without Routine Intraperitoneal Drainage. | Ann Surg | 2017 |
| 28760630 | Predictors and implications of unplanned conversion during minimally invasive hepatectomy: an analysis of the ACS-NSQIP database. | HPB (Oxford) | 2017 |
| 27815139 | miRNA nanotherapeutics for cancer. | Drug Discov Today | 2017 |
| 27743074 | Well-Differentiated, Non-Functional, Non-Ampullary Duodenal Neuroendocrine Tumors: Toward Defining Evaluation and Management. | World J Surg | 2017 |
| 27884544 | Pancreas fistula risk prediction: implications for hospital costs and payments. | HPB (Oxford) | 2017 |
| 27507554 | Restitution of Tumor Suppressor MicroRNA-145 Using Magnetic Nanoformulation for Pancreatic Cancer Therapy. | J Gastrointest Surg | 2017 |
| 27232260 | Incorporation of Procedure-specific Risk Into the ACS-NSQIP Surgical Risk Calculator Improves the Prediction of Morbidity and Mortality After Pancreatoduodenectomy. | Ann Surg | 2017 |
| 26162925 | The Characterization and Prediction of ISGPF Grade C Fistulas Following Pancreatoduodenectomy. | J Gastrointest Surg | 2016 |
| 26563969 | Follicular pancreatitis: a distinct form of chronic pancreatitis-an additional mimic of pancreatic neoplasms. | Hum Pathol | 2016 |
| 26507289 | Surgical management of complicated pancreatic pseudocysts after acute pancreatitis. | Am J Surg | 2016 |
| 26670325 | Comparing the burden of pancreatic fistulas after pancreatoduodenectomy and distal pancreatectomy. | Surgery | 2016 |
| 27730401 | Externalized Stents for Pancreatoduodenectomy Provide Value Only in High-Risk Scenarios. | J Gastrointest Surg | 2016 |
| 27058278 | PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer. | Colloids Surf B Biointerfaces | 2016 |